DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $8,660,000 | +42.2% | 56,424 | +33.8% | 0.06% | +33.3% |
Q3 2019 | $6,089,000 | +8.2% | 42,161 | +7.1% | 0.04% | +4.7% |
Q2 2019 | $5,625,000 | +31.4% | 39,358 | +21.4% | 0.04% | +22.9% |
Q1 2019 | $4,282,000 | +36.1% | 32,428 | +6.3% | 0.04% | +12.9% |
Q4 2018 | $3,146,000 | +15.1% | 30,510 | +21.3% | 0.03% | +10.7% |
Q3 2018 | $2,733,000 | +43.8% | 25,152 | +30.6% | 0.03% | +7.7% |
Q2 2018 | $1,901,000 | +5.7% | 19,262 | +4.9% | 0.03% | +4.0% |
Q1 2018 | $1,798,000 | +15.0% | 18,361 | +9.0% | 0.02% | +19.0% |
Q4 2017 | $1,564,000 | +17.0% | 16,842 | +8.1% | 0.02% | 0.0% |
Q3 2017 | $1,337,000 | -25.5% | 15,584 | -26.8% | 0.02% | -34.4% |
Q2 2017 | $1,795,000 | +47.7% | 21,276 | +49.7% | 0.03% | +28.0% |
Q1 2017 | $1,215,000 | +15.7% | 14,212 | +5.2% | 0.02% | +4.2% |
Q4 2016 | $1,050,000 | +22.1% | 13,505 | +22.9% | 0.02% | +14.3% |
Q3 2016 | $860,000 | -45.3% | 10,989 | -29.6% | 0.02% | -48.8% |
Q2 2016 | $1,573,000 | – | 15,611 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |